Affiliation:
1. Department of Biostatistics Columbia University New York USA
2. Center for Behavioral Cardiovascular Health Columbia University New York USA
Abstract
An N‐of‐1 trial is a multi‐period crossover trial performed in a single individual, with a primary goal to estimate treatment effect on the individual instead of population‐level mean responses. As in a conventional crossover trial, it is critical to understand carryover effects of the treatment in an N‐of‐1 trial, especially when no washout periods between treatment periods are instituted to reduce trial duration. To deal with this issue in situations where a high volume of measurements are made during the study, we introduce a novel Bayesian distributed lag model that facilitates the estimation of carryover effects, while accounting for temporal correlations using an autoregressive model. Specifically, we propose a prior variance‐covariance structure on the lag coefficients to address collinearity caused by the fact that treatment exposures are typically identical on successive days. A connection between the proposed Bayesian model and penalized regression is noted. Simulation results demonstrate that the proposed model substantially reduces the root mean squared error in the estimation of carryover effects and immediate effects when compared to other existing methods, while being comparable in the estimation of the total effects. We also apply the proposed method to assess the extent of carryover effects of light therapies in relieving depressive symptoms in cancer survivors.
Funder
National Cancer Institute
National Institutes of Health
National Science Foundation of Sri Lanka
Subject
Statistics and Probability,Epidemiology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献